RxDoctor Payments Data

Alexander Izad, MD

Retina Specialist · Terre Haute, INNPI 1265591630

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.8% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Astellas Pharma US Inc at 24.4% of the total. That places this record below the midpoint for retina specialist clinicians in IN, where the typical reported total is $1,015.

$1,015in general payments, 2019–2025

Across 35 payments — averaging $29.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$247
  • Genentech USA, Inc.$221
  • Carl Zeiss Meditec USA, Inc.$166
  • Regeneron Healthcare Solutions, Inc.$115
  • Apellis Pharmaceuticals, Inc.$100
  • Eyepoint US, Inc.$99
  • plus $67 from 4 others

What the payments were for

  • Food & beverage$93192%
  • Education$646%
  • Gifts$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,015 in reported general payments places this provider in the 50th percentile of 21 retina specialist providers in Indiana.

See all retina specialist providers in Indiana

Medicare billing

Part B allowed, 2024
$5,140,965
Medicare patients
1,212
Services billed
98,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate307$14,044
RhopressaNetarsudil Mesylate20$6,342
Fluorometholone82$6,093
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat431$6,008
Ketorolac Tromethamine204$5,927
TobradexTobramycin/Dexamethasone17$4,595
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha320$3,477
Valganciclovir Hcl13$2,970
Latanoprost362$2,567
Brimonidine Tartrate159$2,540
Bromfenac Sodium20$2,330
Difluprednate29$1,991
ErythromycinErythromycin Base104$1,141
MoxifloxacinMoxifloxacin Hcl39$1,104
ValacyclovirValacyclovir Hcl12$763

Paid to pharmacies, not to this prescriber.

Other retina specialist in Terre Haute

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →